KEGG   DRUG: Latozinemab
Entry
D12427                      Drug                                   
Name
Latozinemab (USAN/INN)
Formula
C6484H10078N1720O2037S42
Exact mass
145974.616
Mol weight
146064.4299
Sequence
(Heavy chain)
QVQLQESGPG LVKPSETLSL TCAVSGYSIS SGYYWGWIRQ PPGKGLEWIG TIYHSGSTYY
NPSLKSRVTI SVDTSKNQFS LKLSSVTAAD TAVYYCARQG SIKQGYYGMD VWGQGTTVTV
SSASTKGPSV FPLAPSSKST SGGTAALGCL VKDYFPEPVT VSWNSGALTS GVHTFPAVLQ
SSGLYSLSSV VTVPSSSLGT QTYICNVNHK PSNTKVDKKV EPKSCDKTHT CPPCPAPEAA
GGPSVFLFPP KPKDTLMISR TPEVTCVVVD VSHEDPEVKF NWYVDGVEVH NAKTKPREEQ
YNSTYRVVSV LTVLHQDWLN GKEYKCKVSN KALPASIEKT ISKAKGQPRE PQVYTLPPSR
DELTKNQVSL TCLVKGFYPS DIAVEWESNG QPENNYKTTP PVLDSDGSFF LYSKLTVDKS
RWQQGNVFSC SVMHEALHNH YTQKSLSLSP GK
(Light chain)
DIVMTQSPLS LPVTPGEPAS ISCRSSQSLL RSTGYNYLDW YLQKPGQSPQ LLIYLGSNRA
SGVPDRFSGS GSGTDFTLKI SRAEAEDVGV YYCMQQQEAP LTFGGGTKVE IKRTVAAPSV
FIFPPSDEQL KSGTASVVCL LNNFYPREAK VQWKVDNALQ SGNSQESVTE QDSKDSTYSL
SSTLTLSKAD YEKHKVYACE VTHQGLSSPV TKSFNRGEC
(Disulfide bridge: H22-H96, H149-H205, H225-L219, H231-H'231, H234-H'234, H266-H326, H372-H430, H'22-H'96, H'149-H'205, H'225-L'219, H'266-H'326, H'372-H'430, L23-L93, L139-L199, L'23-L'93, L'139-L'199)
  Type
Peptide
Efficacy
Dementia therapeutic agent
  Type
Monoclonal antibody
Comment
Treatment of dementia
Target
SORT1 [HSA:6272] [KO:K12388]
  Pathway
hsa04722  Neurotrophin signaling pathway
Brite
Target-based classification of drugs [BR:br08310]
 Not elsewhere classified
  Cellular process
   Membrane trafficking
    SORT1
     D12427  Latozinemab (USAN/INN)
Other DBs
CAS: 2376132-27-1
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system